Arrowhead Pharmaceuticals, Inc. (ARWR)

66.22 -3.40 (-4.88%) USD  |  NASDAQ  |  Dec 30, 12:13
More

Arrowhead Pharmaceuticals Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Quarterly) Benchmarks

View Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Olema Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. --